609-375-6525
中文
Home
Chemexpress
About Us
Our Culture
Development Path
Awards
Social Responsibility
Contact Us
Platforms
Complex Multi-chiral Drug Technology Platform
Drug Solid-state Chemistry Research Technology Platform
High Potency Active Pharmaceutical Ingredient (HPAPI) Development Platform
Vitamin D Derivative Drug API R&D Platform
Featured Targeted Drug Development Platform
Development and Incubation Platform of Building Block and Reference Compound Libraries
Services
Customized Synthesis Services
Process R&D Services
APIs and Intermediates Production Services
Quality Research & Registration Application Services
Products
Active Pharmaceutical Ingredients (APIs) & Intermediates
Vitamin D Derivatives
High-potency Complex Molecular Drugs
Antibody-drug Conjugates (ADCs)
Building Blocks & Reference Compounds
News
Chemexpress News
Investor
Company Announcement
Stock Quotes
Investor Education
Contact Detail
Investor Exchange Platform
Join Us
Social Recruitment
Campus Recruitment
Promotion and Development
Welfare
Explore
Home
Chemexpress
返回
About Us
Our Culture
Development Path
Awards
Social Responsibility
Contact Us
Platforms
返回
Complex Multi-chiral Drug Technology Platform
Drug Solid-state Chemistry Research Technology Platform
High Potency Active Pharmaceutical Ingredient (HPAPI) Development Platform
Vitamin D Derivative Drug API R&D Platform
Featured Targeted Drug Development Platform
Development and Incubation Platform of Building Block and Reference Compound Libraries
Services
Products
返回
Active Pharmaceutical Ingredients (APIs) & Intermediates
Vitamin D Derivatives
High-potency Complex Molecular Drugs
Antibody-drug Conjugates (ADCs)
Building Blocks & Reference Compounds
News
返回
Chemexpress News
Investor
返回
Company Announcement
Stock Quotes
Investor Education
Contact Detail
Investor Exchange Platform
Join Us
返回
Social Recruitment
Campus Recruitment
Promotion and Development
Welfare
Search
Chemexpress
About Us
Our Culture
Development Path
Awards
Social Responsibility
Contact Us
Platforms
Complex Multi-chiral Drug Technology Platform
Drug Solid-state Chemistry Research Technology Platform
High Potency Active Pharmaceutical Ingredient (HPAPI) Development Platform
Vitamin D Derivative Drug API R&D Platform
Featured Targeted Drug Development Platform
Development and Incubation Platform of Building Block and Reference Compound Libraries
Services
Customized Synthesis Services
Process R&D Services
APIs and Intermediates Production Services
Quality Research & Registration Application Services
Products
Active Pharmaceutical Ingredients (APIs) & Intermediates
Vitamin D Derivatives
High-potency Complex Molecular Drugs
Antibody-drug Conjugates (ADCs)
Building Blocks & Reference Compounds
News
Chemexpress News
Investor
Company Announcement
Stock Quotes
Investor Education
Stock Quotes
Investor Exchange Platform
Join Us
Social Recruitment
Campus Recruitment
Promotion and Development
Welfare
609-375-6525
中文
Home
Chemexpress
About Us
Our Culture
Development Path
Awards
Social Responsibility
Contact Us
Platforms
Complex Multi-chiral Drug Technology Platform
Drug Solid-state Chemistry Research Technology Platform
High Potency Active Pharmaceutical Ingredient (HPAPI) Development Platform
Vitamin D Derivative Drug API R&D Platform
Featured Targeted Drug Development Platform
Development and Incubation Platform of Building Block and Reference Compound Libraries
Services
Customized Synthesis Services
Process R&D Services
APIs and Intermediates Production Services
Quality Research & Registration Application Services
Products
Active Pharmaceutical Ingredients (APIs) & Intermediates
Vitamin D Derivatives
High-potency Complex Molecular Drugs
Antibody-drug Conjugates (ADCs)
Building Blocks & Reference Compounds
News
Chemexpress News
Investor
Company Announcement
Stock Quotes
Investor Education
Contact Detail
Investor Exchange Platform
Join Us
Social Recruitment
Campus Recruitment
Promotion and Development
Welfare
Explore
Home
Chemexpress
返回
About Us
Our Culture
Development Path
Awards
Social Responsibility
Contact Us
Platforms
返回
Complex Multi-chiral Drug Technology Platform
Drug Solid-state Chemistry Research Technology Platform
High Potency Active Pharmaceutical Ingredient (HPAPI) Development Platform
Vitamin D Derivative Drug API R&D Platform
Featured Targeted Drug Development Platform
Development and Incubation Platform of Building Block and Reference Compound Libraries
Services
Products
返回
Active Pharmaceutical Ingredients (APIs) & Intermediates
Vitamin D Derivatives
High-potency Complex Molecular Drugs
Antibody-drug Conjugates (ADCs)
Building Blocks & Reference Compounds
News
返回
Chemexpress News
Investor
返回
Company Announcement
Stock Quotes
Investor Education
Contact Detail
Investor Exchange Platform
Join Us
返回
Social Recruitment
Campus Recruitment
Promotion and Development
Welfare
Search
Chemexpress
About Us
Our Culture
Development Path
Awards
Social Responsibility
Contact Us
Platforms
Complex Multi-chiral Drug Technology Platform
Drug Solid-state Chemistry Research Technology Platform
High Potency Active Pharmaceutical Ingredient (HPAPI) Development Platform
Vitamin D Derivative Drug API R&D Platform
Featured Targeted Drug Development Platform
Development and Incubation Platform of Building Block and Reference Compound Libraries
Services
Customized Synthesis Services
Process R&D Services
APIs and Intermediates Production Services
Quality Research & Registration Application Services
Products
Active Pharmaceutical Ingredients (APIs) & Intermediates
Vitamin D Derivatives
High-potency Complex Molecular Drugs
Antibody-drug Conjugates (ADCs)
Building Blocks & Reference Compounds
News
Chemexpress News
Investor
Company Announcement
Stock Quotes
Investor Education
Stock Quotes
Investor Exchange Platform
Join Us
Social Recruitment
Campus Recruitment
Promotion and Development
Welfare
News
Home
>
News
>
Chemexpress News
First time first dynamic
Chemexpress News
Haoyuan Chemexpress has successfully obtained the US FDA DMF filing for Exatecan mesylate
2022-05-23 17:17:05
Haoyuan Chemexpress has successfully obtained the US FDA DMF filing for the API Exatecan mesylate, filing number: MF036708.
+
Chemexpress wishes you a Merry Christmas!
2021-12-25 07:00:00
Merry Christmas
+
Dr. Yonggang Chen has been appointed as the company’s senior vice president and chief technology officer, taking charge of the Haoyuan Chemexpress CDMO business.
2021-12-23 18:00:00
Haoyuan Chemexpress hired Dr. Chen Yonggang as the company’s senior vice president and chief technology officer (CTO).
+
Congratulations on Chemexpress was officially listed in the SSE STAR Market today
2021-06-08 15:10:32
On June 8, 2021, Shanghai Haoyuan Chemexpress Co., Ltd. was officially listed in the SSE STAR Market!
+
New platform, new starting point, new journey, new dream:Ma'anshan Biomedical Public Service Platform Grand Opening
2021-01-26 17:59:04
On January 25, 2021, the opening ceremony of the Ma'anshan Biomedical Public Service Platform was held in Ningma Science and Technology Innovation Park, Cihu High-tech Zone, Ma'anshan, Anhui Province.
+
2020 CPhI China Chemexpress and industry partners seek common development
2020-12-18 17:24:23
The 3-day exhibition (2020 CPhI China) came to a successful conclusion at Shanghai New International Expo Centre.
+
1
2
3
4
5
6
7
一键拨号
一键导航